{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T05:24:50Z","timestamp":1762233890005,"version":"build-2065373602"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Anti-glomerular basement membrane (GBM) disease is a rapidly progressive glomerulonephritis which, in rare instances, occurs concurrently with membranous nephropathy (MN). We report a case of this patient presented with proteinuria and hematuria, the predominant pathology was crescentic and necrotizing glomerulonephritis with linear staining for immunoglobulin G (IgG) along the glomerular basement membrane (GBM) associated with epi-membranous electron dense immune deposits. The patient tested had significant titers of anti-GBM antibodies (196.27 RU\/ml; reference range:0\u201320 RU\/ml), and renal biopsy demonstrated diffuse strongly positive granular staining for phospholipase a2 receptor (PLA2R) along the GBM. The patient received therapy including prednisone, plasmapheresis and CD20 antibodies, which resulted in the clearance of anti-GBM antibodies and eventual recovery of renal function, as evidenced by the return of serum creatinine to normal levels. Earlier diagnosis and timely effective treatments could improve patients' prognosis.<\/jats:p>","DOI":"10.3389\/fmed.2025.1654203","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T05:22:29Z","timestamp":1762233749000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Concurrent anti-glomerular basement membrane disease and membranous nephropathy: a case report"],"prefix":"10.3389","volume":"12","author":[{"given":"Lin-Lin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Yuan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Xia","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41581-020-0329-y","article-title":"Complexities of the glomerular basement membrane","volume":"17","author":"Naylor","year":"2021","journal-title":"Nat Rev Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1097\/IMNA-D-23-00014","article-title":"Diagnosis and treatment of membranous nephropathy in integrative medicine","volume":"11","author":"Bi","year":"2024","journal-title":"Integr Med Nephrol Androl"},{"key":"B3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.kint.2017.03.014","article-title":"Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients","volume":"92","author":"McAdoo","year":"2017","journal-title":"Kidney Int"},{"key":"B4","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrneph.2013.190","article-title":"Glomerular disease: MN linked to improved prognosis in anti-GBM disease","volume":"9","author":"Holmes","year":"2013","journal-title":"Nat Rev Nephrol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"876512","DOI":"10.3389\/fphar.2022.876512","article-title":"Case report: coexistence of anti-glomerular basement membrane disease, membranous nephropathy, and IgA nephropathy in a female patient with preserved renal function","volume":"13","author":"Qu","year":"2022","journal-title":"Front Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/ki.2013.364","article-title":"The clinical and immunological features of patients with combined anti-glomerular basement membrane disease and membranous nephropathy","volume":"85","author":"Jia","year":"2014","journal-title":"Kidney Int"},{"key":"B7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/j.ajkd.2020.11.023","article-title":"Concurrent anti-glomerular basement membrane antibody disease and membranous nephropathy: a case series","volume":"78","author":"Ahmad","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1080\/0886022X.2022.2141645","article-title":"Clinical and pathological features of anti-glomerular basement membrane disease associated with membranous nephropathy: an observational study","volume":"44","author":"Zhang","year":"2022","journal-title":"Ren Fail."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e56672","DOI":"10.7759\/cureus.56672","article-title":"Concomitant case of anti-glomerular basement membrane (gbm) antibody disease and membranous nephropathy","volume":"16","author":"Phadke","year":"2024","journal-title":"Cureus"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1016\/j.ekir.2023.07.031","article-title":"The characteristics of concurrent anti-glomerular basement membrane nephritis and membranous nephropathy","volume":"8","author":"Bu","year":"2023","journal-title":"Kidney Int Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1297107","DOI":"10.3389\/fimmu.2023.1297107","article-title":"Clinicopathological and prognostic characteristics of idiopathic membranous nephropathy with dual antigen positivity","volume":"14","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1368457","DOI":"10.3389\/fmed.2024.1368457","article-title":"Specific antigens in malignancy-associated membranous nephropathy","volume":"11","author":"Hu","year":"2024","journal-title":"Front Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e00028","DOI":"10.1097\/IMNA-D-22-00028","article-title":"Diagnosis of fibrillary glomerulonephritis with positive immunoglobulin a-\u03ba deposits presenting as membranous nephropathy using immunoelectron microscopy: a case report and literature review","volume":"10","author":"Li","year":"2023","journal-title":"Integr Med Nephrol Androl"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e00007","DOI":"10.1097\/IMNA-D-23-00007","article-title":"IgG4-related disease with IgG1-dominant membranous nephropathy: a rare case report","volume":"10","author":"Duan","year":"2023","journal-title":"Integr Med Nephrol Androl"},{"key":"B15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41401-023-01148-w","article-title":"Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1\/\u03b2-catenin pathway","volume":"45","author":"Miao","year":"2023","journal-title":"Acta Pharmacol Sinica"},{"key":"B16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/bph.16219","article-title":"Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites","volume":"181","author":"Miao","year":"2023","journal-title":"Br J Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1441017","DOI":"10.3389\/fimmu.2024.1441017","article-title":"The fate of immune complexes in membranous nephropathy","volume":"15","author":"Xu","year":"2024","journal-title":"Front Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000505443","article-title":"Epitope Mapping of Human alpha3(IV)NC1-Induced Membranous Nephropathy in Mice","volume":"51","author":"Wang","year":"2020","journal-title":"Am J Nephrol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/08860220500461195","article-title":"Concurrent antiglomerular basement membrane disease and immune complex glomerulonephritis","volume":"28","author":"Cui","year":"2006","journal-title":"Ren Fail"},{"key":"B20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12882-023-03132-2","article-title":"Primary membranous nephropathy in two siblings with one combined with anti-glomerular basement membrane disease: a case report","volume":"24","author":"Cheng","year":"2023","journal-title":"BMC Nephrol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e00010","DOI":"10.1097\/IMNA-D-22-00010","article-title":"The combination therapy of glucocorticoids, tacrolimus, and mycophenolate mofetil in primary membranous nephropathy coexisting with type 2 Diabetes mellitus: a retrospective study","volume":"10","author":"Wang","year":"2023","journal-title":"Integr Med Nephrol Androl"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1335936","DOI":"10.3389\/fimmu.2023.1335936","article-title":"Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy","volume":"14","author":"Jiang","year":"2024","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1504646","DOI":"10.3389\/fimmu.2024.1504646","article-title":"Efficacy analysis of rituximab in treating patients with primary membranous nephropathy dependent on calcineurin inhibitors","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2400539","DOI":"10.1080\/0886022X.2024.2400539","article-title":"Plasmapheresis, immunosuppressive therapy and anti-GBM disease prognosis: a cohort study of 107 patients","volume":"46","author":"Liu","year":"2024","journal-title":"Ren Fail"},{"key":"B25","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1093\/ndt\/gfad268","article-title":"Efficacy of rituximab for patients with anti-glomerular basement membrane disease","volume":"39","author":"Chen","year":"2024","journal-title":"Nephrol Dial Transplant"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1654203\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T05:22:30Z","timestamp":1762233750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1654203\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":25,"alternative-id":["10.3389\/fmed.2025.1654203"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1654203","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"article-number":"1654203"}}